NAD+ (Nicotinamide Adenine Dinucleotide)
Also known as: NAD · NAD Therapy · IV NAD+
NAD+ is a cellular coenzyme central to mitochondrial energy production, DNA repair, and longevity signaling. Provider-reviewed NAD+ optimization is delivered via IV or precursor-based pathways and is positioned in the longevity, recovery, and cognitive support arc.
Serves as a required cofactor for sirtuin and PARP enzymes involved in DNA repair, mitochondrial function, and cellular energy metabolism. Levels decline with age.
What you need to know
NAD+ levels fall measurably with age and under chronic metabolic or inflammatory stress. Restoring NAD+ supports mitochondrial output, sirtuin-mediated longevity pathways, and PARP-driven DNA repair. Optimization pathways include IV NAD+ and precursor strategies (NMN, NR). Provider-reviewed candidacy review weighs cardiovascular context, current medications, and biomarker baseline. NAD+ is positioned as longevity infrastructure rather than a symptomatic intervention.
How this entity relates
Every entity in the oMeds knowledge graph cross-links to the conditions, biomarkers, medications, and educational surfaces it touches.
Bring this entity into your optimization pathway
Every condition, symptom, biomarker, and medication on oMeds is reviewed by a licensed provider and recalibrated against the standardized biomarker panel.